Labcorp to Acquire Certain Assets of OPKO Health's BioReference Health Subsidiary for $722 Million

08:16 AM EDT, 10/15/2026 (MT Newswires) -- Labcorp (LH) has agreed to acquire select assets of OPKO Health (OPK) subsidiary BioReference Health for $722 million, the companies said Thursday. The purchase price includes up to an additional $150 million in an earnout based on revenue from BioReference Health's 4Kscore prostate cancer detection test, the companies said. Under the deal, Labcorp will acquire BioReference Health's laboratory testing businesses, including over 80 patient service centers., they said. Labcorp expects the business revenue to be approximately $250 million in the first year after close, a statement said. The deal is subject to regulatory approvals.